An MC4R antagonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

HS-024 (trifluoroacetate salt)

Item No. 41557

Technical Information
Formal Name
cyclic (1→9)-disulfide, N-acetyl-L-cysteinyl-L-norleucyl-L-arginyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-L-tryptophylglycyl-L-cysteinamide, trifluoroacetate salt
Synonyms
  • Ac-Cys-Nle-Arg-His-D-Nal-Arg-Trp-Gly-Cys-NH2
  • cyclic [AcCys3,Nle4,Arg5,D-Nal7,Cys-NH211]α-MSH-(3–11)
Molecular Formula
C58H79N19O10S2 • XCF3COOH
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥10 mg/mEthanol: Soluble: ≥10 mg/mlPBS (pH 7.2): Soluble: ≥10 mg/ml
SMILES
O=C([C@@H](NC([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CSSC[C@H](NC(CNC1=O)=O)C(N)=O)NC(C)=O)=O)CCCC)=O)CCCNC(N)=N)=O)CC2=CN=CN2)=O)CC3=CC4=C(C=CC=C4)C=C3)=O)CCCNC(N)=N)N[C@H]1CC5=CNC6=CC=CC=C56.O=C(O)C(F)(F)F
InChi Code
InChI=1S/C58H79N19O10S2.C2HF3O2/c1-3-4-14-40-51(82)72-41(16-9-20-65-57(60)61)53(84)77-45(25-37-27-64-31-69-37)55(86)75-43(23-33-18-19-34-11-5-6-12-35(34)22-33)54(85)73-42(17-10-21-66-58(62)63)52(83)76-44(24-36-26-67-39-15-8-7-13-38(36)39)50(81)68-28-48(79)71-46(49(59)80)29-88-89-30-47(56(87)74-40)70-32(2)78;3-2(4,5)1(6)7/h5-8,11-13,15,18-19,22,26-27,31,40-47,67H,3-4,9-10,14,16-17,20-21,23-25,28-30H2,1-2H3,(H2,59,80)(H,64,69)(H,68,81)(H,70,78)(H,71,79)(H,72,82)(H,73,85)(H,74,87)(H,75,86)(H,76,83)(H,77,84)(H4,60,61,65)(H4,62,63,66);(H,6,7)/t40-,41-,42-,43+,44-,45-,46-,47-;/m0./s1
InChi Key
KFPPOAMKLLTSNH-KMPRNXRMSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    HS-024 is a cyclic peptide antagonist of melanocortin receptor 4 (MC4R; Ki = 0.29 nM).1 It is selective for MC4R over MC1R, MC3R, and MC5R (Kis = 18.6, 5.45, and 3.29 nM, respectively). HS-024 (100 nM) inhibits cAMP accumulation induced by α-melanocyte-stimulating hormone (α-MSH; Item No. 29923) in COS-1 cells expressing human MC1R, MC3R, MC4R, or MC5R. It increases food intake in rats when administered at doses of 0.3, 1, or 3 nmol/animal. Intrathecal administration of HS-024 (1.5 nmol/animal) inhibits mechanical allodynia at 30 minutes post-injection in a rat model of spinal nerve ligation-induced neuropathic pain.2 It reduces stress-induced reinstatement of nicotine seeking in the foot shock test in rats.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kask, A., Mutulis, F., Muceniece, R., et alDiscovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): Evaluation in vitro and in vivo. Endocrinology 139(12), 5006-5014 (1998).

    2. Bertorelli, R., Fredduzzi, S., Tarozzo, G., et alEndogenous and exogenous melanocortin antagonists induce anti-allodynic effects in a model of rat neuropathic pain. Behav. Brain Res. 157(1), 55-62 (2005).

    3. Qi, X., Yamada, H., Corrie, L.W., et alA critical role for the melanocortin 4 receptor in stress-induced relapse to nicotine seeking in rats. Addict. Biol. 20(2), 324-335 (2015).